Trendingnow
Tech

By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026


By Carolina Rossini and The ConversationAugust 28, 2026

By Kaitlyn Huamani and The Associated PressAugust 28, 2026

By Kamal AhmedAugust 27, 2026

By Catherina GioinoAugust 28, 2026
Latest stories from Fortune
More TechPage 45 of 100

By Nick LichtenbergJune 8, 2026

By Catherina GioinoJune 8, 2026

By Kristin StollerJune 8, 2026

By Lily Mae LazarusJune 8, 2026

By Kamal AhmedJune 8, 2026

By Andrew NuscaJune 8, 2026

By Jim EdwardsJune 8, 2026

By Francesca CassidyJune 8, 2026

By Nick LichtenbergJune 8, 2026

By Jason MaJune 7, 2026

By Yoolim Lee and BloombergJune 7, 2026

By Jason MaJune 7, 2026

By Amedeo Goria and BloombergJune 7, 2026

By Eva RoytburgJune 7, 2026

By Jeran Wittenstein, Henry Ren and BloombergJune 7, 2026

By Marco Quiroz-GutierrezJune 7, 2026

By Jacqueline MunisJune 7, 2026

By Jacqueline MunisJune 7, 2026

By Bhaskar ChakravortiJune 7, 2026

By Bailey Lipschultz, Vildana Hajric and BloombergJune 6, 2026

By Jason MaJune 6, 2026

By Isabelle Lee and BloombergJune 6, 2026

By Joey Cappelletti, Seung Min Kim and The Associated PressJune 6, 2026

By Chan Ho-Him and The Associated PressJune 6, 2026

By Rory McDonaldJune 6, 2026

By Amanda GerutJune 6, 2026
Most Popular



















